Works matching IS 2160763X AND DT 2021 AND VI 10 AND IP 12

Results: 14

Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1469, doi. 10.1002/cpdd.966

By:

Na, Joo Young;
Jeon, Inseung;
Yoon, Jangsoo;
Choi, Yewon;
Yoon, Seo Hyun;
Yu, Kyung‐Sang;
Chung, Jae‐Yong

Publication type:

Article

A Bioequivalence Study of Avanafil in Healthy Chinese Male Subjects Under Fasting and Fed Conditions: Results of a Randomized, Open‐Label, Single‐Dose, 2‐Sequence, 2‐Period Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1495, doi. 10.1002/cpdd.998

By:

Ren, Xiuhua;
Yu, Hengyi;
Qi, Xingxing;
Chen, Qian;
Yang, Jingwen;
Fang, Yinian;
Lei, Yongfang;
Zhang, Donglin;
Zuo, Qin;
Liu, Dong

Publication type:

Article

An Open‐Label, Randomized, 2‐Way, Crossover Bioequivalence Study of Cefradine Capsules in Healthy Chinese Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1478, doi. 10.1002/cpdd.991

By:

Lai, Xiuping;
Ye, Suiwen;
Chen, Liuhan;
Chen, Junyi;
Zhang, Nan;
Zhang, Yiwen;
Wu, Junyan;
Yao, Herui

Publication type:

Article

Pharmacokinetics and Bioequivalence Evaluation of 2 Formulations of Tenofovir Alafenamide.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1519, doi. 10.1002/cpdd.985

By:

Li, Zhihui;
Liu, Jingyan;
Ju, Gehang;
Yan, Keyu;
Mao, Yong;
Liu, Qingchun;
Yang, Xinlu;
Zhang, Rong;
Qiu, Wen

Publication type:

Article

Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1442, doi. 10.1002/cpdd.969

By:

Trivedi, Ashit;
Oberoi, Rajneet K.;
Mackowski, Mia;
Jafarinasabian, Pegah;
Zhang, Hanze;
Flach, Stephen;
Hutton, Shauna;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

Pharmacokinetics and Bioequivalence Study of a New Branded Generic Moxifloxacin Tablet Among Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1514, doi. 10.1002/cpdd.964

By:

Amran, Atiqah;
Tan, Ching Yee;
Tan, Ka‐Liong;
Ho, Ranald Malcom;
Anand, Anil Kumar;
Leong, Chuei Wuei

Publication type:

Article

First‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Pirepemat, a Cortical Enhancer, in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1485, doi. 10.1002/cpdd.959

By:

Rein‐Hedin, Erik;
Sjöberg, Folke;
Waters, Susanna;
Sonesson, Clas;
Waters, Nicholas;
Huss, Fredrik;
Tedroff, Joakim

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1405, doi. 10.1002/cpdd.839
Publication type:: Article

Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials?

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1410, doi. 10.1002/cpdd.1044

By:

Hirano, Masaru;
Yamada, Masanori;
Tanaka, Toshiaki;
Koue, Toshiko;
Saito, Tomohisa;
Higashimori, Mitsuo;
Ochiai, Hisao;
Yamamoto, Junichi;
Yaguchi, Saori;
Mita, Sachiko;
Hara, Katsutoshi

Publication type:

Article

Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1419, doi. 10.1002/cpdd.1029

By:

Mahar, Kelly M.;
Caltabiano, Stephen;
Andrews, Susan;
Ramanjineyulu, Bandi;
Chen, Liangfu;
Young, Graeme;
Pereira, Adrian;
Lindsay, Alistair C.;
van den Berg, Frans;
Cobitz, Alexander R.

Publication type:

Article

Lack of a Clinically Meaningful Drug Interaction Between the HIV‐1 Antiretroviral Agents Islatravir, Dolutegravir, and Tenofovir Disoproxil Fumarate.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1432, doi. 10.1002/cpdd.1026

By:

Rudd, Deanne Jackson;
Zhang, Saijuan;
Fillgrove, Kerry L.;
Fox‐Bosetti, Sabrina;
Matthews, Randolph P.;
Friedman, Evan;
Armas, Danielle;
Stoch, S. Aubrey;
Iwamoto, Marian

Publication type:

Article

A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1452, doi. 10.1002/cpdd.1014

By:

Liu, Hui;
Wang, Feng;
Ji, Yongjia;
Ma, Tianyang;
Li, Hongying;
Linnebjerg, Helle;
Chua, Laiyi;
Tham, Lai San;
Yu, Yerong

Publication type:

Article

Randomized, Double‐Blind, Controlled Study to Evaluate Safety and Pharmacokinetics of Single Ascending Doses of ASP5354, an Investigational Imaging Product, in Healthy Adult Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1460, doi. 10.1002/cpdd.1013

By:

Murase, Tosei;
Takizawa, Masaomi;
Galitz, Lawrence;
Flach, Stephen;
Murray, Valene;
Gufford, Brandon;
Suwa, Akira

Publication type:

Article

Population Pharmacokinetic Model Development and Simulation for Recombinant Erwinia Asparaginase Produced in Pseudomonas fluorescens (JZP‐458).

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1503, doi. 10.1002/cpdd.1002

By:

Lin, Tong;
Dumas, Todd;
Kaullen, Josh;
Berry, N. Seth;
Choi, Mi Rim;
Zomorodi, Katie;
Silverman, Jeffrey A.

Publication type:

Article